Initiate

With decades of experience in global Market Access and HEOR consultancy, we serve clients who need to achieve the best access outcome. By combining the optimal mix of knowledge, experience and capability across pharmaceuticals, medical devices and diagnostics and with specialist expertise in advanced gene and cell therapies for rare disorders, we guide and support our clients working with novel products aimed at helping those with life-limiting disease

Launch strategy,market access,positioning strategy,launch planning,payer insight,pre-launch pricing strategy,value proposition,value proposition development,value demonstration,tender strategy platform,hta’s submissions,pricing submissions,reimbursement submissions,advanced therapies,novel medicine,and rare disorders

Initiate operates in the Pharmaceutical manufacturing industry.

Initiate's revenue is 11m - 100m

Initiate has 11 - 50 employees.